UROpedia CANADA

PROGRAMS ON DEMAND | Access anytime, anywhere!

All CUA educational programs have undergone official approval process and are the intellectual property of the Canadian Urological Association (CUA). Reproduction of these documents in any form requires the express written consent of the CUA.
For any permission requests, comments/feedback, or to enquire about program content, please contact: tal.erdman@cua.org

 

clinicaltool

PCbutton

CUAJ December 2022: Staged vs. simultaneous bilateral nephrectomy and kidney transplantation in patients with autosomal dominant polycystic kidney disease

Section 3
Max. Credits: 3.0
December 2022

CUAJ October 2022: Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada

Section 3
Max. Credits: 3.0
October 2022

CUAJ August 2022: Testicular cancer survivorship: Long-term toxicity and management

Section 3
Max. Credits: 3.0
August 2022

CUAJ June 2022: A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer

Section 3
Max. Credits: 3.0
June 2022

CUAJ April 2022: Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context

Section 3
Max. Credits: 3.0
April 2022

CUAJ February 2022: Use of imaging for active surveillance in testicular cancer: Is real-world practice concordant with guidelines?

Section 3
Max. Credits: 3.0
February 2022

CUAJ December 2021: Use of cannabis in urological cancer patients

Section 3
Max. Credits: 3.0
December 2021

CUAJ October 2021: Adult Transgender Care

Section 3
Max. Credits: 3.0
October 2021

CUAJ June 2021: Availability of platelet-rich plasma for treatment of ED

Section 3
Max. Credits: 3.0
June 2021